What the Options Market Tells Us About Iovance Biotherapeutics
Portfolio Pulse from Benzinga Insights
Investors with significant capital have taken a bullish stance on Iovance Biotherapeutics (NASDAQ: IOVA), as evidenced by recent options trading activity. Benzinga's options scanner identified 8 trades, with 75% being bullish. The expected price range for IOVA is between $7.0 and $9.0. The stock is currently trading at $9.22, up by 25.78%, with a neutral RSI. An analyst from Piper Sandler downgraded the stock to Neutral with a $10 price target.
August 08, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Significant investors have shown a bullish stance on Iovance Biotherapeutics, with 75% of recent options trades being calls. The stock is currently trading at $9.22, up by 25.78%. An analyst from Piper Sandler downgraded the stock to Neutral with a $10 price target.
The bullish sentiment from significant investors, as indicated by the options trades, suggests a positive short-term outlook for IOVA. The stock's recent price increase and the analyst's price target of $10 further support this view.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100